価格表

在庫・価格 : 2025年04月30日 15時43分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Human VEGF R1/Flt-1 Quantikine ELISA Kit, 3rd Gen
データシート※最新のデータシートでない場合があります
DVR100C RSDアールアンドディー システムズ
R&D Systems, Inc.
1 kit ¥116,000 3個以上 追加

在庫・価格 : 2025年04月30日 15時43分 現在

Human VEGF R1/Flt-1 Quantikine ELISA Kit, 3rd Gen

  • 商品コード:DVR100C
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥116,000
  • 在庫:3個以上
使用文献
No. 文献情報 備考 参照
1 Jeyabalan A et al. Effect of smoking on circulating angiogenic factors in high risk pregnancies. PLoS ONE 2010;5(10):e13270
Jeyabalan A et al
2010/01/01
Species: Human PubMed
2 Owen LA et al. FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression. Invest. Ophthalmol. Vis. Sci. 2014 Jun;55(6):3543-54
Owen LA et al
2014/01/01
Species: Human PubMed
3 Braicu EI et al. Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: results of a companion protocol of the randomized, NOGGO-AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. ca
Braicu EI et al
2013/01/01
Species: Human PubMed
4 Necchi A et al. Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy. Br. J. Cancer 2014 Jan;110(1):26-33
Necchi A et al
2014/01/01
Species: Human PubMed
5 Justiniano SE et al. Fcγ receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies. J. Biol. Chem. 2013 Sep;288(37):26800-9
Justiniano SE et al
2013/01/01
Species: Human PubMed
6 Dutta A et al. Household air pollution and angiogenic factors in pregnant Nigerian women: A randomized controlled ethanol cookstove intervention. Sci. Total Environ. 2017 Dec;599-600:2175-2181
Dutta A et al
2017/01/01
Species: Human PubMed
7 Patten IS et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012 May;485(7398):333-8
Patten IS et al
2012/01/01
Species: Human PubMed
8 Clavel G et al. Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin. Immunol. 2007 Aug;124(2):158-64
Clavel G et al
2007/01/01
Species: Human PubMed
9 Mross K et al. Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours. Eur. J. Cancer 2005 Jun;41(9):1291-9
Mross K et al
2005/01/01
Species: Human PubMed
10 Dubois SG et al. Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study. Clin. Cancer Res. 2011 Aug;17(15):5113-22
Dubois SG et al
2011/01/01
Species: Human PubMed
11 Liu LY et al. Integrating multiple 'omics' analyses identifies serological protein biomarkers for preeclampsia. BMC Med 2013;11:236
Liu LY et al
2013/01/01
Species: Human PubMed
12 Sallinen H et al. Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice. Mol. Ther. 2009 Feb;17(2):278-84
Sallinen H et al
2009/01/01
Species: Human PubMed
13 Findley CM et al. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J. Am. Coll. Cardiol. 2008 Jul;52(5):387-93
Findley CM et al
2008/01/01
Species: Human PubMed
14 Maynard SE et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 2003 Mar;111(5):649-58
Maynard SE et al
2003/01/01
Species: Human PubMed
15 Verlohren S et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am. J. Obstet. Gynecol. 2010 Feb;202(2):161.e1-161.e11
Verlohren S et al
2010/01/01
Species: Human PubMed
16 Kosugi T et al. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice. Am. J. Physiol. Renal Physiol. 2010 Mar;298(3):F609-16
Kosugi T et al
2010/01/01
Species: Human PubMed
17 Huang QT et al. Advanced oxidation protein products enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia. Placenta 2013 Oct;34(10):949-52
Huang QT et al
2013/01/01
Species: Human PubMed
18 Gutman G et al. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis. Fertil. Steril. 2008 Apr;89(4):922-6
Gutman G et al
2008/01/01
Species: Human PubMed
19 Jeevaratnam K et al. Periodic assessment of plasma sFlt-1 and PlGF concentrations and its association with placental morphometry in gestational hypertension (GH) - a prospective follow-up study. BMC Pregnancy Childbirth 2010;10:58
Jeevaratnam K et al
2010/01/01
Species: Human PubMed
20 Masuyama H et al. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Am. J. Obstet. Gynecol. 2006 Feb;194(2):551-6
Masuyama H et al
2006/01/01
Species: Human PubMed
21 Sallinen H et al. Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer. BMC Cancer 2014;14:696
Sallinen H et al
2014/01/01
Species: Human PubMed
22 Sandhofer A et al. Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study. Atherosclerosis 2009 Sep;206(1):265-9
Sandhofer A et al
2009/01/01
Species: Human PubMed
23 Landt S et al. In vitro vascular tube formation testing as a tool for treatment individualisation in patients with cervical cancer. Anticancer Res. 2011 Aug;31(8):2609-15
Landt S et al
2011/01/01
Species: Human PubMed
24 Eslani M et al. Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1. Invest. Ophthalmol. Vis. Sci. 2017 10;58(12):5507-5517
Eslani M et al
2017/01/01
Species: Human PubMed
25 Levine RJ et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004 Feb;350(7):672-83
Levine RJ et al
2004/01/01
Species: Human PubMed
26 El-Tarhouny SA et al. Placental growth factor and soluble Fms-like tyrosine kinase 1 in diabetic pregnancy: A possible relation to distal villous immaturity. Histol. Histopathol. 2014 Feb;29(2):259-72
El-Tarhouny SA et al
2014/01/01
Species: Human PubMed
27 Suzuki T et al. A randomized controlled trial of multicomponent exercise in older adults with mild cognitive impairment. PLoS ONE 2013;8(4):e61483
Suzuki T et al
2013/01/01
Species: Human PubMed
28 Landt S et al. Prognostic significance of angiogenic factors in uterine cervical cancer. Anticancer Res. 2011 Aug;31(8):2589-95
Landt S et al
2011/01/01
Species: Human PubMed
29 Levine RJ et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 2006 Sep;355(10):992-1005
Levine RJ et al
2006/01/01
Species: Human PubMed
30 Wallner W et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin. Sci. 2007 Jan;112(1):51-7
Wallner W et al
2007/01/01
Species: Human PubMed
31 Sandgren JA et al. Arginine vasopressin infusion is sufficient to model clinical features of preeclampsia in mice. JCI Insight 2018 10;3(19)
Sandgren JA et al
2018/01/01
PubMed
32 Unger HW et al. Sulphadoxine-pyrimethamine plus azithromycin may improve birth outcomes through impacts on inflammation and placental angiogenesis independent of malarial infection. Sci Rep 2019 Feb;9(1):2260
Unger HW et al
2019/01/01
PubMed
33 Lee SHS et al. Intravitreal Injection of AAV Expressing Soluble VEGF Receptor-1 Variant Induces Anti-VEGF Activity and Suppresses Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2018 11;59(13):5398-5407
Lee SHS et al
2018/01/01
PubMed
34 Pantho AF et al. Synthetic Receptors Induce Anti Angiogenic and Stress Signaling on Human First Trimester Cytotrophoblast Cells. Int J Environ Res Public Health 2017 05;14(5)
Pantho AF et al
2017/01/01
PubMed
35 Varas-Godoy M et al. Angiogenic Properties of Menstrual Stem Cells Are Impaired in Women with a History of Preeclampsia. Stem Cells Int 2019;2019:1916542
Varas-Godoy M et al
2019/01/01
PubMed
36 Sullivan JA et al. Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain. Gene Ther. 2018 06;25(3):205-219
Sullivan JA et al
2018/01/01
PubMed
37 Tanaka H et al. Arginase controls soluble vascular endothelial growth factor receptor 1 (sFlt1) to maintain pregnancy homeostasis. Biochem. Biophys. Res. Commun. 2018 05;499(2):150-155
Tanaka H et al
2018/01/01
PubMed
38 Buhimschi CS et al. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am. J. Obstet. Gynecol. 2005 Mar;192(3):734-41
Buhimschi CS et al
2005/01/01
PubMed
39 White WM et al. Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury. PLoS ONE 2014;9(3):e92693
White WM et al
2014/01/01
PubMed
40 Zarychta E et al. Anti-angiogenic efficacy in invasive breast carcinoma patients depends on clinicopathological determinants. Adv Med Sci 2019 Feb;64(2):216-223
Zarychta E et al
2019/01/01
PubMed
41 Muehlenbachs A et al. Natural selection of FLT1 alleles and their association with malaria resistance in utero. Proc. Natl. Acad. Sci. U.S.A. 2008 Sep;105(38):14488-91
Muehlenbachs A et al
2008/01/01
PubMed
42 Li H et al. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta ;26(2-3):210-7
Li H et al
PubMed
43 Levine RJ et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005 Jan;293(1):77-85
Levine RJ et al
2005/01/01
PubMed
44 Rahbari NN et al. Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer. BMC Cancer 2011;11:286
Rahbari NN et al
2011/01/01
PubMed
45 Villie P et al. ELABELA concentration is not decreased in maternal plasma before the onset of preeclampsia. Am. J. Obstet. Gynecol. 2019 Mar;220(3):284-285
Villie P et al
2019/01/01
PubMed
46 Caine GJ et al. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer. Cancer Lett. 2007 Apr;248(1):131-6
Caine GJ et al
2007/01/01
PubMed
47 Levine RJ et al. Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study. BMJ 2009;339:b4336
Levine RJ et al
2009/01/01
PubMed
48 Eubank TD et al. GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice. Immunity 2004 Dec;21(6):831-42
Eubank TD et al
2004/01/01
PubMed
49 Powers RW et al. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS ONE 2010;5(10):e13263
Powers RW et al
2010/01/01
PubMed
50 Bessho H et al. Inhibition of placental growth factor in renal cell carcinoma. Anticancer Res. 2015 Jan;35(1):531-41
Bessho H et al
2015/01/01
PubMed
51 Bourlev V et al. Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis. Fertil. Steril. 2010 Jun;94(1):52-7
Bourlev V et al
2010/01/01
PubMed
52 Caine GJ et al. Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients. Cancer Lett. 2007 Jun;251(2):296-301
Caine GJ et al
2007/01/01
PubMed
53 Jeyabalan A et al. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am. J. Hypertens. 2008 Aug;21(8):943-7
Jeyabalan A et al
2008/01/01
PubMed
54 O'Brien M et al. Endothelial Dysfunction in Severe Preeclampsia is Mediated by Soluble Factors, Rather than Extracellular Vesicles. Sci Rep 2017 Jul;7(1):5887
O'Brien M et al
2017/01/01
PubMed
55 Abou Faycal C et al. A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells. Sci Rep 2019 Jan;9(1):336
Abou Faycal C et al
2019/01/01
PubMed
56 Weel IC et al. Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia. PLoS ONE 2016;11(6):e0157584
Weel IC et al
2016/01/01
PubMed
57 Li H et al. LIFR increases the release of soluble endoglin via the upregulation of MMP14 expression in preeclampsia. Reproduction 2018 03;155(3):297-306
Li H et al
2018/01/01
PubMed
58 Panta S et al. Low grade inflammation inhibits VEGF induced HUVECs migration in p53 dependent manner. Biochem. Biophys. Res. Commun. 2017 02;483(2):803-809
Panta S et al
2017/01/01
PubMed
59 Ataga KI et al. Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell Anemia. PLoS ONE ;11(9):e0162652
Ataga KI et al
PubMed
60 Jammalamadaga VS et al. Spectrum of Factors Triggering Endothelial Dysfunction in PIH. J Clin Diagn Res 2016 Dec;10(12):BC14-BC17
Jammalamadaga VS et al
2016/01/01
PubMed
61 St淡dle GS et al. Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. Clin. Exp. Immunol. 2018 Jul;193(1):84-94
St淡dle GS et al
2018/01/01
PubMed
62 Wilson DL et al. Sleep-disordered breathing does not impact maternal outcomes in women with hypertensive disorders of pregnancy. PLoS One 2020;15(4):e0232287
Wilson DL et al
2020/01/01
PubMed
63 Dias MS et al. Retina transduction by rAAV2 after intravitreal injection: comparison between mouse and rat. Gene Ther 2019 12;26(12):479-490
Dias MS et al
2019/01/01
PubMed
64 Scurt FG et al. Systemic Inflammation Precedes Microalbuminuria in Diabetes. Kidney Int Rep 2019 Oct;4(10):1373-1386
Scurt FG et al
2019/01/01
PubMed
65 Nabweyambo S et al. Circulating levels of angiogenic factors and their association with preeclampsia among pregnant women at Mulago National Referral Hospital in Uganda. PLoS One 2021;16(5):e0251227
Nabweyambo S et al
2021/01/01
Species: Human PubMed
66 Rahman RA et al. Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia. Int J Mol Sci 2020 Apr;21(7)
Rahman RA et al
2020/01/01
Species: Human PubMed
67 Nikuei P et al. Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia. BMC Pregnancy Childbirth 2020 Feb;20(1):80
Nikuei P et al
2020/01/01
Species: Human PubMed
  • No.: 1
  • 文献情報:
    Jeyabalan A et al. Effect of smoking on circulating angiogenic factors in high risk pregnancies. PLoS ONE 2010;5(10):e13270
    Jeyabalan A et al
    2010/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Owen LA et al. FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression. Invest. Ophthalmol. Vis. Sci. 2014 Jun;55(6):3543-54
    Owen LA et al
    2014/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Braicu EI et al. Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: results of a companion protocol of the randomized, NOGGO-AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. ca
    Braicu EI et al
    2013/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Necchi A et al. Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy. Br. J. Cancer 2014 Jan;110(1):26-33
    Necchi A et al
    2014/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Justiniano SE et al. Fcγ receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies. J. Biol. Chem. 2013 Sep;288(37):26800-9
    Justiniano SE et al
    2013/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Dutta A et al. Household air pollution and angiogenic factors in pregnant Nigerian women: A randomized controlled ethanol cookstove intervention. Sci. Total Environ. 2017 Dec;599-600:2175-2181
    Dutta A et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Patten IS et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012 May;485(7398):333-8
    Patten IS et al
    2012/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Clavel G et al. Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin. Immunol. 2007 Aug;124(2):158-64
    Clavel G et al
    2007/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Mross K et al. Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours. Eur. J. Cancer 2005 Jun;41(9):1291-9
    Mross K et al
    2005/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Dubois SG et al. Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study. Clin. Cancer Res. 2011 Aug;17(15):5113-22
    Dubois SG et al
    2011/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Liu LY et al. Integrating multiple 'omics' analyses identifies serological protein biomarkers for preeclampsia. BMC Med 2013;11:236
    Liu LY et al
    2013/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Sallinen H et al. Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice. Mol. Ther. 2009 Feb;17(2):278-84
    Sallinen H et al
    2009/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Findley CM et al. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J. Am. Coll. Cardiol. 2008 Jul;52(5):387-93
    Findley CM et al
    2008/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Maynard SE et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 2003 Mar;111(5):649-58
    Maynard SE et al
    2003/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Verlohren S et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am. J. Obstet. Gynecol. 2010 Feb;202(2):161.e1-161.e11
    Verlohren S et al
    2010/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Kosugi T et al. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice. Am. J. Physiol. Renal Physiol. 2010 Mar;298(3):F609-16
    Kosugi T et al
    2010/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Huang QT et al. Advanced oxidation protein products enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia. Placenta 2013 Oct;34(10):949-52
    Huang QT et al
    2013/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Gutman G et al. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis. Fertil. Steril. 2008 Apr;89(4):922-6
    Gutman G et al
    2008/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Jeevaratnam K et al. Periodic assessment of plasma sFlt-1 and PlGF concentrations and its association with placental morphometry in gestational hypertension (GH) - a prospective follow-up study. BMC Pregnancy Childbirth 2010;10:58
    Jeevaratnam K et al
    2010/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Masuyama H et al. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Am. J. Obstet. Gynecol. 2006 Feb;194(2):551-6
    Masuyama H et al
    2006/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Sallinen H et al. Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer. BMC Cancer 2014;14:696
    Sallinen H et al
    2014/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Sandhofer A et al. Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study. Atherosclerosis 2009 Sep;206(1):265-9
    Sandhofer A et al
    2009/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Landt S et al. In vitro vascular tube formation testing as a tool for treatment individualisation in patients with cervical cancer. Anticancer Res. 2011 Aug;31(8):2609-15
    Landt S et al
    2011/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Eslani M et al. Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1. Invest. Ophthalmol. Vis. Sci. 2017 10;58(12):5507-5517
    Eslani M et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Levine RJ et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004 Feb;350(7):672-83
    Levine RJ et al
    2004/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    El-Tarhouny SA et al. Placental growth factor and soluble Fms-like tyrosine kinase 1 in diabetic pregnancy: A possible relation to distal villous immaturity. Histol. Histopathol. 2014 Feb;29(2):259-72
    El-Tarhouny SA et al
    2014/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Suzuki T et al. A randomized controlled trial of multicomponent exercise in older adults with mild cognitive impairment. PLoS ONE 2013;8(4):e61483
    Suzuki T et al
    2013/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Landt S et al. Prognostic significance of angiogenic factors in uterine cervical cancer. Anticancer Res. 2011 Aug;31(8):2589-95
    Landt S et al
    2011/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Levine RJ et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 2006 Sep;355(10):992-1005
    Levine RJ et al
    2006/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Wallner W et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin. Sci. 2007 Jan;112(1):51-7
    Wallner W et al
    2007/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Sandgren JA et al. Arginine vasopressin infusion is sufficient to model clinical features of preeclampsia in mice. JCI Insight 2018 10;3(19)
    Sandgren JA et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Unger HW et al. Sulphadoxine-pyrimethamine plus azithromycin may improve birth outcomes through impacts on inflammation and placental angiogenesis independent of malarial infection. Sci Rep 2019 Feb;9(1):2260
    Unger HW et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Lee SHS et al. Intravitreal Injection of AAV Expressing Soluble VEGF Receptor-1 Variant Induces Anti-VEGF Activity and Suppresses Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2018 11;59(13):5398-5407
    Lee SHS et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Pantho AF et al. Synthetic Receptors Induce Anti Angiogenic and Stress Signaling on Human First Trimester Cytotrophoblast Cells. Int J Environ Res Public Health 2017 05;14(5)
    Pantho AF et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Varas-Godoy M et al. Angiogenic Properties of Menstrual Stem Cells Are Impaired in Women with a History of Preeclampsia. Stem Cells Int 2019;2019:1916542
    Varas-Godoy M et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Sullivan JA et al. Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain. Gene Ther. 2018 06;25(3):205-219
    Sullivan JA et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Tanaka H et al. Arginase controls soluble vascular endothelial growth factor receptor 1 (sFlt1) to maintain pregnancy homeostasis. Biochem. Biophys. Res. Commun. 2018 05;499(2):150-155
    Tanaka H et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Buhimschi CS et al. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am. J. Obstet. Gynecol. 2005 Mar;192(3):734-41
    Buhimschi CS et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    White WM et al. Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury. PLoS ONE 2014;9(3):e92693
    White WM et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Zarychta E et al. Anti-angiogenic efficacy in invasive breast carcinoma patients depends on clinicopathological determinants. Adv Med Sci 2019 Feb;64(2):216-223
    Zarychta E et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Muehlenbachs A et al. Natural selection of FLT1 alleles and their association with malaria resistance in utero. Proc. Natl. Acad. Sci. U.S.A. 2008 Sep;105(38):14488-91
    Muehlenbachs A et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Li H et al. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta ;26(2-3):210-7
    Li H et al
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Levine RJ et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005 Jan;293(1):77-85
    Levine RJ et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Rahbari NN et al. Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer. BMC Cancer 2011;11:286
    Rahbari NN et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Villie P et al. ELABELA concentration is not decreased in maternal plasma before the onset of preeclampsia. Am. J. Obstet. Gynecol. 2019 Mar;220(3):284-285
    Villie P et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Caine GJ et al. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer. Cancer Lett. 2007 Apr;248(1):131-6
    Caine GJ et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Levine RJ et al. Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study. BMJ 2009;339:b4336
    Levine RJ et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Eubank TD et al. GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice. Immunity 2004 Dec;21(6):831-42
    Eubank TD et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Powers RW et al. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS ONE 2010;5(10):e13263
    Powers RW et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Bessho H et al. Inhibition of placental growth factor in renal cell carcinoma. Anticancer Res. 2015 Jan;35(1):531-41
    Bessho H et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Bourlev V et al. Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis. Fertil. Steril. 2010 Jun;94(1):52-7
    Bourlev V et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Caine GJ et al. Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients. Cancer Lett. 2007 Jun;251(2):296-301
    Caine GJ et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Jeyabalan A et al. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am. J. Hypertens. 2008 Aug;21(8):943-7
    Jeyabalan A et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    O'Brien M et al. Endothelial Dysfunction in Severe Preeclampsia is Mediated by Soluble Factors, Rather than Extracellular Vesicles. Sci Rep 2017 Jul;7(1):5887
    O'Brien M et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Abou Faycal C et al. A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells. Sci Rep 2019 Jan;9(1):336
    Abou Faycal C et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Weel IC et al. Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia. PLoS ONE 2016;11(6):e0157584
    Weel IC et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Li H et al. LIFR increases the release of soluble endoglin via the upregulation of MMP14 expression in preeclampsia. Reproduction 2018 03;155(3):297-306
    Li H et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Panta S et al. Low grade inflammation inhibits VEGF induced HUVECs migration in p53 dependent manner. Biochem. Biophys. Res. Commun. 2017 02;483(2):803-809
    Panta S et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Ataga KI et al. Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell Anemia. PLoS ONE ;11(9):e0162652
    Ataga KI et al
  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Jammalamadaga VS et al. Spectrum of Factors Triggering Endothelial Dysfunction in PIH. J Clin Diagn Res 2016 Dec;10(12):BC14-BC17
    Jammalamadaga VS et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    St淡dle GS et al. Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. Clin. Exp. Immunol. 2018 Jul;193(1):84-94
    St淡dle GS et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Wilson DL et al. Sleep-disordered breathing does not impact maternal outcomes in women with hypertensive disorders of pregnancy. PLoS One 2020;15(4):e0232287
    Wilson DL et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Dias MS et al. Retina transduction by rAAV2 after intravitreal injection: comparison between mouse and rat. Gene Ther 2019 12;26(12):479-490
    Dias MS et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Scurt FG et al. Systemic Inflammation Precedes Microalbuminuria in Diabetes. Kidney Int Rep 2019 Oct;4(10):1373-1386
    Scurt FG et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Nabweyambo S et al. Circulating levels of angiogenic factors and their association with preeclampsia among pregnant women at Mulago National Referral Hospital in Uganda. PLoS One 2021;16(5):e0251227
    Nabweyambo S et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Rahman RA et al. Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia. Int J Mol Sci 2020 Apr;21(7)
    Rahman RA et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Nikuei P et al. Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia. BMC Pregnancy Childbirth 2020 Feb;20(1):80
    Nikuei P et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed